BNTC

Benitec Biopharma Inc · NASDAQ

Sector Health Technology
Industry Biotechnology
Website benitec.com
Employees(FY) 18
ISIN US08205P2092

Performance

+3.38%

1W

+98.54%

1M

+218.56%

3M

+164.35%

6M

+193.81%

YTD

+193.81%

1Y

Profile

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

Advanced Technical Analysis

Technical Analysis of BNTC 2024-05-10

Overview:

In analyzing the technical indicators for BNTC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...

See more ...

Recent News & Updates

2024-05-13 02:53
BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024(Investorplace)
2024-05-12 20:15
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update(Globenewswire)
2024-04-30 20:00
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference(Globenewswire)
2024-04-17 19:30
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study(Globenewswire)
2024-04-17 19:00
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million(Globenewswire)
2024-04-08 20:00
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024(Globenewswire)
2024-03-23 19:55
11 Best ASX Stocks To Buy Now(Insidermonkey)
2024-02-12 19:00
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update(Globenewswire)
2023-11-29 18:00
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy(Globenewswire)
2023-11-16 19:00
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference(Globenewswire)
2023-11-12 19:00
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update(Globenewswire)
2023-09-20 20:00
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update(Yahoo Finance)
2023-08-21 09:02
Citadel Advisors LLC Acquires New Stake in Benitec Biopharma Inc(Yahoo Finance)
2023-08-18 09:02
JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec Biopharma Inc(Yahoo Finance)
2023-08-11 01:00
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering(Yahoo Finance)
2023-08-08 10:30
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering(Yahoo Finance)
2023-07-25 01:00
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023(Yahoo Finance)
2023-06-25 20:00
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy(Yahoo Finance)
2023-05-14 20:00
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update(Yahoo Finance)
2023-05-07 20:05
Benitec Biopharma to Present at the OPMD International Conference(Yahoo Finance)
2023-05-07 20:00
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference(Yahoo Finance)
2023-02-12 19:00
Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update(Yahoo Finance)
2023-01-22 20:48
Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program(Yahoo Finance)
2022-11-09 19:00
Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update(Yahoo Finance)
2022-09-15 20:42
Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering(Yahoo Finance)
2022-09-12 10:06
Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering(Yahoo Finance)
2022-09-01 20:00
Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update(Yahoo Finance)
2022-07-14 18:52
Having purchased US$827k worth of Benitec Biopharma Inc. (NASDAQ:BNTC) stock, the recent 11% pullback is not what insiders may have expected(Yahoo Finance)
2022-05-15 20:15
Benitec Biopharma Releases Q3 2022 Financial Results(Yahoo Finance)
2022-02-13 19:00
Benitec Biopharma Discloses Q2 2022 Financial Results(Yahoo Finance)

Page 1 of 4

previousnext